Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
---|
09/18/2012 | US8268331 Nucleic acid molecules and polypeptides for immune modulation |
09/18/2012 | CA2606521C Dihydropyridine derivatives |
09/18/2012 | CA2501717C Use of epothilone derivatives for the treatment of hyperparathyroidism |
09/18/2012 | CA2388733C Food supplement for increasing lean mass and strength |
09/18/2012 | CA2378943C Super-active porcine growth hormone releasing hormone analog |
09/13/2012 | WO2012122388A2 Chip-last embedded interconnect structures and methods of making the same |
09/13/2012 | WO2012121140A1 Growth hormone secretion promoter |
09/13/2012 | WO2012120476A1 Substituted morpholines as modulators for the calcium sensing receptor |
09/13/2012 | WO2012119559A1 Androgen receptor antagonists and uses thereof |
09/13/2012 | WO2012053003A8 A novel herbal oil for controlling blood sugar without risk of hypoglycemea |
09/13/2012 | WO2011103130A8 Aminothiazolones as estrogen related receptor-alpha modulators |
09/13/2012 | US20120232071 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds |
09/13/2012 | US20120232056 Heterocyclic compounds for the inhibition of pask |
09/13/2012 | US20120232050 Cyclic Inhibitors of 11 beta-Hydroxysteroid Dehydrogenase 1 |
09/13/2012 | US20120232009 Methods for Treatment of Insulin-Like Growth Factor-1 Deficiency |
09/13/2012 | US20120232004 Methods for Treating Autoimmune Disorders, and Reagents Related Thereto |
09/13/2012 | US20120231085 Controlled release compositions of gamma-hydroxybutyrate |
09/13/2012 | US20120230947 Biologically active proteins having increased in vivo and/or in vitro stability |
09/13/2012 | US20120230911 Tnf-alpha binding proteins |
09/13/2012 | CA2829322A1 Androgen receptor antagonists and uses thereof |
09/13/2012 | CA2828415A1 Substituted morpholines as modulators for the calcium sensing receptor |
09/12/2012 | CN102666586A Drug fusions and conjugates with extended half life |
09/12/2012 | CN102666531A Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof |
09/12/2012 | CN102666508A Phenyloxadiazole derivatives as pgds inhibitors |
09/12/2012 | CN102659944A IL-18 binding proteins |
09/12/2012 | CN102657640A PTP1B (protein tyrosine phosphatase 1B) inhibition activity of norathyriol, and application of norathyriol |
09/12/2012 | CN102657639A Application of carthamin yellow to aspects of reducing fat and increasing sensitivity of insulin |
09/12/2012 | CN101760446B Method for preparing monocyte type stem cell and application |
09/12/2012 | CN101715956B Multifunctional health juice with stable effective ingredients and processing method thereof |
09/12/2012 | CN101583598B Novel indole derivative having inhibitory activity on i kappa b kinase |
09/12/2012 | CN101506221B Estratriene derivatives and their uses as 17beta-hydroxysteroid dehydrogenase inhibitors |
09/12/2012 | CN101189251B 17 beta-HSD1 and STS inhibitors |
09/11/2012 | US8263647 Treatment of sleep disturbances |
09/11/2012 | US8263084 Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate |
09/11/2012 | US8262054 Furnace mount |
09/07/2012 | WO2012080284A3 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof |
09/07/2012 | CA2829020A1 Parathyroid hormone analogs, compositions and uses thereof |
09/06/2012 | US20120225955 Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin |
09/06/2012 | US20120225945 Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof |
09/06/2012 | US20120225906 Piperidine renin inhibitors |
09/06/2012 | US20120225890 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease |
09/06/2012 | US20120225887 Glucokinase Activators |
09/06/2012 | US20120225883 Compounds for inflammation and immune-related uses |
09/06/2012 | US20120225878 Compounds |
09/06/2012 | US20120225876 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
09/06/2012 | US20120225865 Arylcyclohexylethers of dihydrotetraazabenzoazulenes |
09/06/2012 | US20120225863 Heterocyclic compounds for the inhibition of pask |
09/06/2012 | US20120225853 Hormone replacement therapy and depression |
09/06/2012 | US20120225846 Heterocyclic compounds for the inhibition of pask |
09/06/2012 | US20120225816 Pharmaceutical Compositions of Melanocortin Receptor Ligands |
09/06/2012 | US20120225118 Compositions for delivery of insoluble agents |
09/06/2012 | US20120225069 Use of a compound for reducing the biological effectiveness of il-6 |
09/06/2012 | US20120225032 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo |
09/06/2012 | DE102011004899A1 New 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl-deriva tives are progesterone receptor antagonists useful to treat and prevent e.g. uterine fibroids, endometriosis, heavy menstrual bleeding and meningioma |
09/05/2012 | EP2493910A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
09/05/2012 | EP2493888A1 Bicyclic pyridines and analogs as sirtuin modulators |
09/05/2012 | EP2493303A1 2- [1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA [F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS |
09/05/2012 | CN102655867A Parenteral pharmaceutical formulation in suspension, having sustained release, in low and ultralow dosage, in hormonal therapy in the climacteric syndrome |
09/05/2012 | CN102652828A Polypeptide-k buccal tablet |
09/05/2012 | CN102652808A Menstruation regulating and beautifying capsule |
09/05/2012 | CN102652757A Application of health-care drinking liquid containing deep seawater in preparation of medicaments or health-care products for preventing or treating metabolic syndrome |
09/05/2012 | CN102652749A Application of 2-cycloxyl substituted or cyclothio substituted hydroxyacetophenone in treatment of metabolic disease |
09/05/2012 | CN102091082B Ginsenoside Rb3 composition and application thereof in preparing medicament for treating diabetes |
09/05/2012 | CN101972315B Use of traditional Chinese medicinal composition |
09/05/2012 | CN101780242B Health or medicine composition and preparation method and application thereof |
09/05/2012 | CN101756955B Chinonin complex, preparation method and application thereof |
09/05/2012 | CN101588804B Method for treating or preventing symptoms of hormonal variations |
09/05/2012 | CN101443016B Use of 4, 17 beta-dihydroxyandrost-4-ene-3-one for treating cancers |
09/04/2012 | US8258293 Tetrahydroquinoline derivatives |
09/04/2012 | US8258252 Lactic acid-glycolic acid polymer having ratio or weight average molecular weight and number average molecular weight of about 1.90 or lower, or a salt thereof, and a physiologically active substance; for treating prostate cancer, prostatomegaly, endometriosis, hysteromyoma, metrofibroma, breast cancer |
09/04/2012 | US8258134 Pyridazinone glucokinase activators |
09/04/2012 | US8258096 Therapy procedure for drug delivery for trigeminal pain |
09/04/2012 | US8257691 Composition and dosage form comprising a particle formulation and suspending vehicle |
09/04/2012 | CA2507429C Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
08/30/2012 | WO2012116176A2 Asymmetric ureas and medical uses thereof |
08/30/2012 | WO2012115241A1 Fcγriib-specific fc antibody |
08/30/2012 | WO2012115064A1 Ppar activator |
08/30/2012 | US20120220629 Asymmetric ureas and medical uses thereof |
08/30/2012 | US20120220592 2-phenylethylamino derivatives as calcium and/or sodium channel modulators |
08/30/2012 | US20120220567 Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors |
08/30/2012 | US20120220558 Methods of Treating Hormone-Related Conditions Using Thio-Oxindole Derivatives |
08/30/2012 | US20120220556 Drospirenone for hormone replacement therapy |
08/30/2012 | US20120219567 Methods Relating to Peripheral Administration of Nogo Receptor Polypeptides |
08/30/2012 | US20120219546 Methods for treating conditions mediated by the inflammatory cytokine cascade using gapdh inhibitors |
08/30/2012 | CA2827923A1 Fc.gamma.riib-specific fc antibody |
08/29/2012 | EP2490702A1 Treatment using reprogrammed mature adult cells |
08/29/2012 | EP2490678A1 Coated capsules and tablets of a fatty acid oil mixture |
08/29/2012 | EP2490674A2 Melt-granulated cinacalcet |
08/29/2012 | CN1820782B Thyroid hormone medicinal preparation and its preparing method |
08/29/2012 | CN102038721B Pinus extract and application thereof |
08/29/2012 | CN101108878B Glp-1 analogues |
08/28/2012 | US8252745 Methods for treatment of headaches by administration of oxytocin |
08/28/2012 | CA2508171C Nicotinamide-based kinase inhibitors |
08/28/2012 | CA2479414C Inhibition of the .beta.3 subunit of l-type ca2+ channels |
08/28/2012 | CA2453337C Methods and materials for the treatment of testosterone deficiency in men |
08/28/2012 | CA2395632C A bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
08/23/2012 | US20120214841 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
08/23/2012 | US20120214806 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines |
08/23/2012 | US20120214777 Stabilized compositions containing alkaline labile drugs |
08/23/2012 | US20120214773 Formulation for lipophilic agents |